Stay updated on Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.

Latest updates to the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page
- Check2 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4 with no observable impact on content or functionality.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded 'Results Submitted' status and a new 'Locations' section listing California, Florida, and Tennessee, replacing the previous state-location headings; the page now shows Revision: v3.3.3.SummaryDifference0.4%

- Check52 days agoChange DetectedThe page now shows a new revision label (v3.3.2) and removes the previous label (v3.2.0). This appears to be a minor version update with no visible changes to core study content or user actions, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedA government funding/operating status notice was removed from the page. The core study information remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedMinor updates observed (e.g., last updated timestamp and formatting tweaks). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange DetectedMajor update to operational notice and a version upgrade to v3.2.0; old v3.1.0 version reference removed.SummaryDifference3%

Stay in the know with updates to Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.